Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19.

Larsson, Anders O; Hultström, Michael; Frithiof, Robert; Lipcsey, Miklos; Eriksson, Mats B

Larsson, Anders O; Hultström, Michael; Frithiof, Robert; Lipcsey, Miklos; Eriksson, Mats B.

Afiliação

Larsson AO; Department of Medical Sciences, Section of Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
Hultström M; Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, 751 85 Uppsala, Sweden.
Frithiof R; Department of Medical Cell Biology, Integrative Physiology, Uppsala University, 751 23 Uppsala, Sweden.
Lipcsey M; Department of Epidemiology, McGill University, Montréal, QC H3A 0G4, Canada.
Eriksson MB; Lady Davis Institute of Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada.

Int J Mol Sci ; 23(24)2022 Dec 10.

Article em En | MEDLINE | ID: mdl-36555328

Assuntos

COVID-19; Rim; Feminino; Humanos; Masculino; COVID-19/complicações; Creatinina; Cistatina C; Dexametasona/uso terapêutico; Taxa de Filtração Glomerular/fisiologia; Síndrome; Rim/fisiopatologia

Palavras-chave

COVID-19 creatinine; SARS-CoV-2; SPS; biomarker; corticosteroids; cystatin C; eGFR; gender; intensive care; shrunken pore syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Rim Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google